AHSP Conference Addresses Drug Misadventures Strategies to minimize the problem of drug misadventures were the result of a meeting convened by the American Society of Hospital Pharmacists (now the American Society of Health-System Pharmacists), the American Medical Association and the American Nurses Association and held in Chantilly, Virginia. The conference was said to have been the first multidisciplinary effort of its kind, and is part of a multi-step drug misadventure prevention project by the ASHP's Research Foundation, funded by a grant from Abbott Labs.
Preliminary review indicates that conference suggestions centered on the need for:
- a multidisciplinary approach in all activities designed to reduce medication errors;
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze